000			01832 a2200529 4500
005			20250514021726.0
264		0	_c20020320
008			200203s 0 0 eng d
022			_a1528-9117
040			_aNLM _beng _cNLM
100	1		_aReinmuth, N
245	0	0	_aEndothelial survival factors as targets for antineoplastic therapy. _h[electronic resource]
260			_bCancer journal (Sudbury, Mass.) _c
300			_aS109-19 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAngiopoietin-1
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCell Survival
650	0	4	_aEndothelial Growth Factors _xantagonists & inhibitors
650	0	4	_aEndothelium, Vascular _xdrug effects
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aIntegrins _xmetabolism
650	0	4	_aLymphokines _xantagonists & inhibitors
650	0	4	_aMembrane Glycoproteins _xtherapeutic use
650	0	4	_aNeoplasms _xblood supply
650	0	4	_aNeovascularization, Pathologic _xprevention & control
650	0	4	_aOxindoles
650	0	4	_aPericytes _xmetabolism
650	0	4	_aPropionates
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReceptor, TIE-2
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aStoeltzing, O
700	1		_aLiu, W
700	1		_aAhmad, S A
700	1		_aJung, Y D
700	1		_aFan, F
700	1		_aParikh, A
700	1		_aEllis, L M
773	0		_tCancer journal (Sudbury, Mass.) _gvol. 7 Suppl 3 _gp. S109-19
999			_c11690900 _d11690900